Phospho-EGF receptor (TYR1 EA and 9 more items

George Mason University (GMU) in Virginia awarded a contract to Cell Signaling Technology on July 21, 2026, with a cumulative value of $3,430.00. The contract encompasses the procurement of ten antibody and protein products for delivery to GMU Purchasing. These research-grade reagents include phosphorylated protein antibodies—such as phospho-EGF (epidermal growth factor) receptor, phospho-AKT, phospho-P44/42 MAPK (extracellular signal-regulated kinases 1 and 2), phospho-FAK (focal adhesion kinase), and phospho-STAT3 (signal transducer and activator of transcription 3)—as well as corresponding non-phosphorylated variants and related antibodies. Unit prices for individual line items range from $179.00 to $463.00.

The contract deliverables consist of single-unit purchases of specialized antibody products commonly utilized in life sciences research applications. All items are designated for delivery to GMU Purchasing, indicating institutional research support purposes. Cell Signaling Technology, as the prime contractor, will supply these molecular biology reagents to support George Mason University's research initiatives. The contract award represents a standard procurement of laboratory research materials required for protein analysis and signal transduction pathway studies.